These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1061 related items for PubMed ID: 25770175

  • 1. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL, Molina P, Cerverón MJ, Vila R, Bover J, Nieto J, Barril G, Martínez-Castelao A, Fernández E, Escudero V, Piñera C, Adragao T, Navarro-Gonzalez JF, Molinero LM, Castro-Alonso C, Pallardó LM, Jamal SA.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):654-66. PubMed ID: 25770175
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of coexisting retinopathy and vascular calcification on chronic kidney disease progression and cardiovascular events.
    Hwang HS, Kim SY, Hong YA, Cho WK, Chang YK, Shin SJ, Yang CW, Kim SY, Yoon HE.
    Nutr Metab Cardiovasc Dis; 2016 Jul 07; 26(7):590-596. PubMed ID: 27089976
    [Abstract] [Full Text] [Related]

  • 3. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
    Chaikriangkrai K, Nabi F, Mahmarian JJ, Chang SM.
    Int J Cardiovasc Imaging; 2015 Dec 07; 31(8):1619-26. PubMed ID: 26243534
    [Abstract] [Full Text] [Related]

  • 4. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 5. Vascular calcification in patients undergoing kidney and simultaneous pancreas-kidney transplantation.
    Chau K, Martinez G, Elder GJ.
    Nephrology (Carlton); 2014 May 05; 19(5):275-81. PubMed ID: 24506475
    [Abstract] [Full Text] [Related]

  • 6. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V, Sastre C, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2016 Mar 07; 11(3):413-22. PubMed ID: 26728587
    [Abstract] [Full Text] [Related]

  • 7. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D, Lancaster RT, Ergul E, Bertges D, Goodney P, Schermerhorn ML, Cambria RP, Patel VI, Vascular Study Group of New England.
    J Vasc Surg; 2016 Nov 07; 64(5):1295-1302. PubMed ID: 27776697
    [Abstract] [Full Text] [Related]

  • 8. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease.
    Tatami Y, Yasuda Y, Suzuki S, Ishii H, Sawai A, Shibata Y, Ota T, Shibata K, Niwa M, Morimoto R, Hayashi M, Kato S, Maruyama S, Murohara T.
    Atherosclerosis; 2015 Dec 07; 243(2):349-55. PubMed ID: 26519631
    [Abstract] [Full Text] [Related]

  • 9. Vascular calcification in long-term kidney transplantation.
    Vipattawat K, Kitiyakara C, Phakdeekitcharoen B, Kantachuvesiri S, Sumethkul V, Jirasiritham S, Stitchantrakul W, Disthabanchong S.
    Nephrology (Carlton); 2014 Apr 07; 19(4):251-6. PubMed ID: 24447254
    [Abstract] [Full Text] [Related]

  • 10. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
    Chiu DY, Kalra PA, Sinha S, Green D.
    Nephrology (Carlton); 2016 Jun 07; 21(6):476-82. PubMed ID: 26426983
    [Abstract] [Full Text] [Related]

  • 11. Association of symptoms of depression with progression of CKD.
    Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC.
    Am J Kidney Dis; 2012 Jul 07; 60(1):54-61. PubMed ID: 22495469
    [Abstract] [Full Text] [Related]

  • 12. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):352-7. PubMed ID: 22566286
    [Abstract] [Full Text] [Related]

  • 13. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
    Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, Vanholder R, Diouf M, Choukroun G, Massy ZA, European Uremic Toxin Work Group (EUTox).
    Kidney Int; 2012 Dec 01; 82(12):1297-303. PubMed ID: 22895515
    [Abstract] [Full Text] [Related]

  • 14. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
    De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali C, Postorino M, Iodice C, Nappi F, Fuiano G, Gallo C, Conte G, Italian Society of Nephrology Study Group Target Blood pressure Levels (TABLE) in CKD.
    Kidney Int; 2012 Aug 01; 82(4):482-8. PubMed ID: 22622495
    [Abstract] [Full Text] [Related]

  • 15. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Rakugi H, Isaka Y.
    Clin Exp Nephrol; 2017 Apr 01; 21(2):333-341. PubMed ID: 27178276
    [Abstract] [Full Text] [Related]

  • 16. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.
    J Am Heart Assoc; 2017 Jul 05; 6(7):. PubMed ID: 28679558
    [Abstract] [Full Text] [Related]

  • 17. Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.
    Wang XR, Yuan L, Zhang JJ, Hao L, Wang DG.
    Nephrology (Carlton); 2017 Apr 05; 22(4):286-292. PubMed ID: 27165564
    [Abstract] [Full Text] [Related]

  • 18. Participation in a Structured Weight Loss Program and All-Cause Mortality and Cardiovascular Morbidity in Obese Patients With Chronic Kidney Disease.
    MacLaughlin HL, Hall WL, Condry J, Sanders TA, Macdougall IC.
    J Ren Nutr; 2015 Nov 05; 25(6):472-9. PubMed ID: 26143293
    [Abstract] [Full Text] [Related]

  • 19. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL, Lafrance JP, Lu SE, Soroka O, Miller DR, Maney M, Pogach LM.
    BMC Nephrol; 2015 Mar 25; 16():34. PubMed ID: 25885708
    [Abstract] [Full Text] [Related]

  • 20. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG, Uecer E, Stadler S, Birner C, Buchner S, Maier LS, Luchner A.
    Nephrology (Carlton); 2016 Jun 25; 21(6):490-8. PubMed ID: 26422793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.